毒蕈碱型乙酰胆碱受体 1 参与人心房肌细胞的内向整流钾电流,并在慢性心房颤动患者中上调。
Muscarinic type-1 receptors contribute to I in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.
机构信息
Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Essen, Germany; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Department of Pharmacology and Toxicology, Carl Gustav Carus Medical Faculty, Dresden University of Technology, Dresden, Germany.
出版信息
Int J Cardiol. 2018 Mar 15;255:61-68. doi: 10.1016/j.ijcard.2017.12.050. Epub 2017 Dec 22.
BACKGROUND
Basal and acetylcholine-gated inward-rectifier K-currents (I and I, respectively) are altered in atrial fibrillation (AF). G-protein-coupled muscarinic (M) receptors type-2 are considered the predominant receptors activating I. Although a role for G-coupled non-M-receptor subtypes has been suggested, the precise regulation of I by multiple M-receptor subtypes in the human atrium is unknown. Here, we investigated M-receptor-mediated I regulation and its remodeling in chronic AF (cAF).
METHODS AND RESULTS
M-receptor mRNA and protein abundance were increased in atrial cardiomyocyte fractions and atrial homogenates from cAF patients, whereas M-receptor levels were unchanged. The regulation of I by M-receptors was investigated in right-atrial cardiomyocytes using two applications of the M-receptor agonist carbachol (CCh, 2μM), with pharmacological interventions during the second application. CCh application produced a rapid current increase (Peak-I), which declined to a quasi-steady-state level (Qss-I). In sinus rhythm (Ctl) the selective M-receptor antagonists pirenzepine (10nM) and muscarinic toxin-7 (MT-7, 10nM) significantly inhibited CCh-activated Peak-I, whereas in cAF they significantly reduced both Peak- and Qss-I, with no effects on basal inward-rectifier currents in either group. Conversely, the selective M-receptor agonist McN-A-343 (100μM) induced a current similar to the CCh-activated current in Ctl atrial cardiomyocytes pretreated with pertussis toxin to inhibit M-receptor-mediated G-protein signaling, which was abolished by MT-7. Computational modeling indicated that M- and M-receptors redundantly activate I to abbreviate APD, albeit with predominant effects of M-receptors.
CONCLUSION
Our data suggest that G-coupled M-receptors also regulate human atrial I and that their relative contribution to I activation is increased in cAF patients. We provide novel insights about the role of non-M-receptors in human atrial cardiomyocytes, which may have important implications for understanding AF pathophysiology.
背景
基础和乙酰胆碱门控内向整流钾电流(分别为 I 和 I)在心房颤动(AF)中发生改变。G 蛋白偶联毒蕈碱(M)受体 2 型被认为是激活 I 的主要受体。尽管已经提出了 G 偶联非 M 受体亚型的作用,但在人类心房中,多种 M 受体亚型对 I 的精确调节尚不清楚。在这里,我们研究了 M 受体介导的 I 调节及其在慢性 AF(cAF)中的重塑。
方法和结果
在 cAF 患者的右心房肌细胞和心房匀浆中,M 受体 mRNA 和蛋白丰度增加,而 M 受体水平不变。使用 M 受体激动剂 carbachol(CCh,2μM)的两次应用,在第二次应用期间进行药理学干预,研究 M 受体对 I 的调节。CCh 应用产生快速电流增加(峰电流),该电流下降至准稳态水平(Qss-I)。在窦性节律(Ctl)中,选择性 M 受体拮抗剂 pirenzepine(10nM)和 muscarinic 毒素-7(MT-7,10nM)显著抑制 CCh 激活的峰电流,而在 cAF 中,它们显著降低峰电流和 Qss-I,而对两组的基础内向整流电流均无影响。相反,选择性 M 受体激动剂 McN-A-343(100μM)在预先用百日咳毒素处理以抑制 M 受体介导的 G 蛋白信号传导的 Ctl 心房肌细胞中诱导类似于 CCh 激活的电流,该电流被 MT-7 消除。计算建模表明,M-和 M 受体冗余地激活 I 以缩短 APD,尽管 M 受体的作用占主导地位。
结论
我们的数据表明,G 偶联 M 受体也调节人类心房 I,并且在 cAF 患者中,它们对 I 激活的相对贡献增加。我们提供了关于非 M 受体在人类心房肌细胞中的作用的新见解,这对于理解 AF 病理生理学可能具有重要意义。
相似文献
Naunyn Schmiedebergs Arch Pharmacol. 2009-9-17
Circ Arrhythm Electrophysiol. 2010-7-24
Biochim Biophys Acta. 2003-9-23
引用本文的文献
Pharmaceuticals (Basel). 2024-7-29
Physiol Res. 2024-4-18
Naunyn Schmiedebergs Arch Pharmacol. 2024-8
Naunyn Schmiedebergs Arch Pharmacol. 2024-4
Cardiovasc Res. 2023-5-22
Biomedicines. 2022-11-17
Front Cardiovasc Med. 2022-9-15
本文引用的文献
Card Electrophysiol Clin. 2016-6
Prog Biophys Mol Biol. 2016-1
Circulation. 2013-10-1
Biophys J. 2013-9-17